Exparel Interscalene vs Indwelling Catheter

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE2

Total Enrollment

23 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-01-22

Study Completion Date

2021-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators are comparing an indwelling catheter with intermediate duration local anesthetic to a single shot peripheral nerve block with long acting a local anesthetic (Exparel).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Exparel vs Exparel Plus ACB in TKAs

NCT02365727

Knee Osteoarthritis

WITHDRAWN PHASE4

Exparel for Total Shoulder Arthroplasty

NCT04364867

Total Shoulder Arthroplasty

COMPLETED PHASE4

Peri-articular Injection Utilizing a Pain Cocktail With and Without Exparel

NCT02571283

Total Knee Arthroplasty Pain Management

WITHDRAWN PHASE4

Exparel for Total Shoulder Pain

NCT03739021

Chronic Shoulder Pain

NOT_YET_RECRUITING PHASE2/PHASE3

Evaluation Exparel Delivered in Knee Replacement

NCT02011464

Arthritis

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

While placing an indwelling nerve catheter can prolong pain control, it can also have drawbacks and complications. While major complications like pneumothorax and hemidiaphragmatic paresis from interscalene continuous peripheral nerve blocks (CPNB) are rare, minor adverse effects associated with CPNBs may be more common. They include infection and anatomical damage to blood vessels and nerves due to the indwelling catheter. In addition, catheters take a significantly longer time to set up and place than single shot blocks, which is important as there is often a rush to block patients and trying to get them into the operating room on time. Furthermore, the needle used for catheter placement is larger than the single shot needles, which creates more discomfort to patients during the nerve block. The catheter itself is taped around the entire sides and back of the patient's neck, which is also uncomfortable for patients. Because of how shallow the interscalene block is, the catheter is often found to be dislodged from operating room positioning, patient transport or movement, which negates the placement of the catheter. An indwelling catheter must also be followed up by the acute pain service team until the catheter is removed.

Exparel, or liposomal bupivacaine, is formulated to release low dose bupivacaine over 96 hours, and was recently approved by the FDA in April 2018 to be used in interscalene blocks. The sustained release of local anesthetic could theoretically act similarly to the continuous infusion of local anesthetic through an indwelling interscalene catheter, and could thus avoid the need for placement of a catheter. Current existing data, although inconclusive, has in some studies shown an equal analgesic effect as catheters. As per pharmacy, the cost of the On-Q pump and the local anesthesia needed for the pump together cost $390 for each indwelling catheter placed, not including the cost of anesthesia and pharmacy supplies and labor. The cost of each 20 mL vial of Exparel is less at $285 and, for a single shot nerve block, would avoid the extra costs and time needed for a catheter placement.

The investigators would like to perform a prospective randomized controlled pilot study to examine the efficacy of single shot interscalene blocks using Exparel versus the traditional interscalene catheter used at our institution. The purpose of the study the investigators are proposing is to determine if single shot interscalene nerve blocks using Exparel can provide equivalent or better analgesia than indwelling interscalene catheter in patients who undergo total shoulder replacement surgery. If so, single shot interscalene nerve blocks with Exparel may serve as a quicker, easier, cheaper, safer, and more comfortable alternative to placing indwelling interscalene catheters.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single shot Interscalene Nerve Block

This group will receive an interscalene nerve block. This will be administered as a single 20mL injection consisting of a mixture of 10mL of Exparel and 10mL of 0.5% bupivacaine hydrochloride.

Group Type EXPERIMENTAL

Exparel

Intervention Type DRUG

A shot of long acting local anesthetic for post operative pain management

Indwelling Interscalene Catheter

This group will receive an indwelling interscalene catheter placed posterior to C5-C6 nerve roots (between the shoulders) and administered 15 mL of 0.5% ropivacaine plain for the block with no superficial cervical block. The "On-Q" pump will be set at a rate of 4 mL/hr.

Group Type ACTIVE_COMPARATOR

Indwelling Interscalene Catheter

Intervention Type DEVICE

ropivacaine, given through a catheter inserted between the shoulders

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Exparel

A shot of long acting local anesthetic for post operative pain management

Intervention Type DRUG

Indwelling Interscalene Catheter

ropivacaine, given through a catheter inserted between the shoulders

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

liposomal bupivacaine

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* American Society of Anesthesia (ASA) 1, 2, and 3
* Ages 40-74
* Patients scheduled for total shoulder replacement

Exclusion Criteria

* ASA 4 and 5
* Pre-existing pain disorder
* Regular consumption of chronic pain medication
* pregnant women
* any medical condition such as a clotting disorder
* anatomic abnormality that precludes use of an indwelling scalene catheter
* Body Mass Index (BMI) \>40
* Patient refusal
* Pre-existing diabetic neuropathy or Hemoglobin A1c \>9
* Failed block

Minimum Eligible Age

40 Years

Maximum Eligible Age

74 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No